Oakbrook Investments’s Acadia Healthcare ACHC Stock Holding History

Oakbrook Investments’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-6,100	Closed	-$291K	–	563
2017 Q3	$291K	Buy	+6,100	New	+$297K	0.02%	454

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Oakbrook Investments's ACHC Position: Q4 2017 in Review

Oakbrook Investments sold out of Acadia Healthcare (ACHC) in Q4 2017, closing a stake of 6,100 shares — an estimated $291K sold.

Oakbrook Investments first reported a position in ACHC in Q3 2017 and held it in 1 quarter. The position peaked at $291K in Q3 2017. 262 funds tracked by Wall St. Rank hold ACHC as of Q4 2017.

Oakbrook Investments reported no remaining Acadia Healthcare position as of Q4 2017 after selling out during the quarter.
Oakbrook Investments sold 6,100 Acadia Healthcare shares in Q4 2017, an estimated $291K.
Oakbrook Investments first reported a position in Acadia Healthcare in Q3 2017 and held it in 1 quarter.
Oakbrook Investments's Acadia Healthcare position peaked at $291K in Q3 2017.
262 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2017.

Based on Oakbrook Investments's 13F filing for Q4 2017, filed 18 Jan 2018.